Amgen
AMGN
AMGN
2,422 hedge funds and large institutions have $98.4B invested in Amgen in 2023 Q1 according to their latest regulatory filings, with 130 funds opening new positions, 1,038 increasing their positions, 887 reducing their positions, and 146 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,422
Holders Change
-69
Holders Change %
-2.77%
% of All Funds
38.76%
Holding in Top 10
65
Holding in Top 10 Change
-34
Holding in Top 10 Change %
-34.34%
% of All Funds
1.04%
New
130
Increased
1,038
Reduced
887
Closed
146
Calls
$1.48B
Puts
$1.19B
Net Calls
+$296M
Net Calls Change
+$260M
Top Buyers
| 1 |
UBS AM
Chicago,
Illinois
|
+$800M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$356M |
| 3 |
SP
Sarasin & Partners
London,
United Kingdom
|
+$354M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$211M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$210M |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$524M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$451M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$366M |
| 4 |
D.E. Shaw & Co
New York
|
-$225M |
| 5 |
Barclays
London,
United Kingdom
|
-$223M |
